715 related articles for article (PubMed ID: 12835212)
1. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators.
Himmrich E; Przibille O; Zellerhoff C; Liebrich A; Rosocha S; Andreas K; Nebeling D; Omogbehin B; Meyer J
Circulation; 2003 Jul; 108(2):192-7. PubMed ID: 12835212
[TBL] [Abstract][Full Text] [Related]
2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
3. [Combination use of an automatic anti-tachycardia pacemaker and an automatic implantable cardioverter-defibrillator in sustained recurrent ventricular tachycardia resistant to drugs].
Benedini G; Caradonna E; Alfieri O; Visioli O
G Ital Cardiol; 1989 Oct; 19(10):889-900. PubMed ID: 2612809
[TBL] [Abstract][Full Text] [Related]
4. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].
Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R
G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313
[TBL] [Abstract][Full Text] [Related]
5. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
[TBL] [Abstract][Full Text] [Related]
8. [Automatic implantable cardioverter-defibrillator (AICD) and antitachycardia pacemaker (Tachylog 651) in the treatment of ventricular tachyarrhythmias].
Gerckens U; Manz M; Funke HD; Kirchhoff PG; Lüderitz B
Z Kardiol; 1987 Apr; 76(4):211-6. PubMed ID: 3604373
[TBL] [Abstract][Full Text] [Related]
9. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
[TBL] [Abstract][Full Text] [Related]
10. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
[TBL] [Abstract][Full Text] [Related]
11. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
14. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
[TBL] [Abstract][Full Text] [Related]
15. Termination of sustained ventricular tachycardia with a new antitachycardia pacemaker: role of the nonautomatic mode to follow pacemaker function.
Fromer M; Kus T; Page P; Shenasa M
Can J Cardiol; 1989; 5(1):42-6. PubMed ID: 2920305
[TBL] [Abstract][Full Text] [Related]
16. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
Lo R; Mitrache A; Quan W; Cohen TJ
J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
[TBL] [Abstract][Full Text] [Related]
17. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
[TBL] [Abstract][Full Text] [Related]
18. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
19. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study.
Klug D; Balde M; Pavin D; Hidden-Lucet F; Clementy J; Sadoul N; Rey JL; Lande G; Lazarus A; Victor J; Barnay C; Grandbastien B; Kacet S;
Circulation; 2007 Sep; 116(12):1349-55. PubMed ID: 17724263
[TBL] [Abstract][Full Text] [Related]
20. Reduction of ICD shock burden by eliminating back-up pacing induced ventricular tachyarrhythmias.
Theis C; Mollnau H; Sonnenschein S; Konrad T; Himmrich E; Bock K; Schulz E; Kämpfner D; Gerhardt S; Quesada Ocete B; Münzel T; Rostock T
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):889-895. PubMed ID: 24654876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
